Evidence map›Paper›PMID 33680330›Full record

ReviewJournal of clinical and experimental dentistry2021

Indications of the extraction of symptomatic impacted third molars. A systematic review.

María Peñarrocha-Diago, Octavi Camps-Font, Alba Sánchez-Torres, Rui Figueiredo, María-Angeles Sánchez-Garcés, Cosme Gay-Escoda

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of clinical and experimental dentistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

María Peñarrocha-DiagoDDS, MS, PhD. Assistant Professor of Oral Surgery. University of Valencia Medical and Dental School. Valencia, Spain. Researcher of the "Dental and Maxillofacial Diseases and Therapeutics" group of the Bellvitge Biomedical Research Institute (IDIBELL).
Octavi Camps-FontDDS, MS. Associate Professor of Oral Surgery. University of Barcelona Dental School. Barcelona, Spain. Researcher of the "Dental and Maxillofacial Diseases and Therapeutics" group of the Bellvitge Biomedical Research Institute (IDIBELL).
Alba Sánchez-TorresDDS, MS. Associate Professor of Oral Surgery. University of Barcelona Dental School. Barcelona, Spain. Researcher of the "Dental and Maxillofacial Diseases and Therapeutics" group of the Bellvitge Biomedical Research Institute (IDIBELL).
Rui FigueiredoDDS, MS, PhD. Associate Professor of Oral Surgery. Coordinator of the Master of Oral Surgery and Buccofacial Implantology. University of Barcelona. Barcelona, Spain. Researcher of the "Dental and Maxillofacial Diseases and Therapeutics" group of the Bellvitge Biomedical Research Institute (IDIBELL).
María-Angeles Sánchez-GarcésMD, DDS, MS, PhD, EBOS. Associate Professor of Oral Surgery. University of Barcelona Dental School. Barcelona, Spain. Subdirector of the Master of Oral Surgery and Buccofacial Implantology of the EFHRE International University / FUCSO. Researcher of the "Dental and Maxillofacial Diseases and Therapeutics" group of the Bellvitge Biomedical Research Institute (IDIBELL).
Cosme Gay-EscodaMD, DDS, MS, PhD, EBOS, OMFS. Chairman of Oral and Maxillofacial Surgery. University of Barcelona Dental School. Barcelona, Spain. Director of the Master of Oral Surgery and Buccofacial Implantology of the EFHRE International University / FUCSO. Coordinator / Researcher of the "Dental and Maxillofacial Diseases and Therapeutics" group of the Bellvitge Biomedical Research Institute (IDIBELL).
Institut d'Investigació Biomédica de Bellvitge · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA literature review was made to determine when third molar (3M) extraction is recommended in symptomatic patients and when it is not recommended. MATERIAL AND

methodsA Medline (PubMed) and EMBASE search was made for articles related to indications for the extraction of 3Ms, published in the last 10 years and up until September 2018.

resultsThe electronic search yielded 175 articles. After eliminating duplicates, a total of 173 articles were subjected to review of the title and abstract. Only 19 studies were finally included in the systematic review. There was a well documented increase in morbidity associated to impacted 3Ms (non-restorable caries, fracture, infection, periodontal disease, repeated pericoronitis, cysts and tumors), and in the presence of disease, extraction was considered to be indicated. The extraction of 3Ms with signs and/or symptoms of periodontal disease improved periodontal health at the distal surface of the second molar. Postoperative quality of life of patients with symptomatic 3Ms and with disease improved after surgical extraction.

conclusionsExtraction is indicated in the presence of disease associated to an impacted 3M, whether symptomatic or not. In contrast, extraction is not indicated in the absence of infection or other associated disease conditions.

Identifiers

PMID33680330
PMCPMC7920557
OpenAlexW3130966015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.